Showing results (2101-2110 of 2,176) with videos related to

Sort By:
Pageof 218
Journal of the American College of Cardiology|August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary DiseaseDaniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
JAMA Cardiology|July 21, 2016
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical TrialDarren K McGuire, Frans Van de Werf, Paul W Armstrong, et al.
The New England Journal of Medicine|June 9, 2015
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 DiabetesJennifer B Green, M Angelyn Bethel, Paul W Armstrong, et al.
European Heart Journal|November 4, 2004
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryEric J Velazquez, Gary S Francis, Paul W Armstrong, et al.
American Heart Journal|December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarctionSean D Pokorney, Christina Radder, Phillip J Schulte, et al.
The New England Journal of Medicine|March 12, 2013
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarctionPaul W Armstrong, Anthony H Gershlick, Patrick Goldstein, et al.
The American Journal of Cardiology|April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Harrington, R H Tuttle, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
Pageof 218